NUVATION BIO INC (NUVB) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:NUVB - US67080N1019 - Common Stock
7.84 USD
-0.16 (-2%)
7.96 USD
+0.12 (+1.53%)
ChartMill assigns a Buy % Consensus number of 84% to NUVB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.65. This target is 35.88% above the current price.
NUVB was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NUVB.
In the previous month the buy percentage consensus was at a similar level.
NUVB was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-20 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-19 | B. Riley Securities | Initiate | Buy |
| 2025-11-04 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-09-30 | Jefferies | Initiate | Buy |
| 2025-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-25 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-06-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-11 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-06-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-04-23 | JMP Securities | Initiate | Market Outperform |
| 2025-03-12 | Jones Trading | Initiate | Buy |
| 2025-03-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-22 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-11 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-08-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
NUVATION BIO INC / NUVB FAQ
What is the average price target for NUVATION BIO INC (NUVB) stock?
16 analysts have analysed NUVB and the average price target is 10.65 USD. This implies a price increase of 35.88% is expected in the next year compared to the current price of 7.84.
What is the consensus rating for NUVB stock?
The consensus rating for NUVATION BIO INC (NUVB) is 83.75 / 100 . This indicates that analysts generally have a positive outlook on the stock.